Diversity Equity And Inclusion In The Pharma Industry Statistics

Diversity, equity, and inclusion in pharma is changing how talent moves—from hiring and promotions to retention and day-to-day belonging. Across the U.S. and global settings, companies use tools like unconscious bias training, diverse candidate slates, and employee resource groups, with DEI-linked KPIs for leaders. We also look at measurable outcomes, including shifts in executive representation, engagement, and turnover trends for women and racial and ethnic groups.

Key Takeaways

92% of large pharma companies invested over $10M in DEI initiatives in 2023
78% of pharma firms implemented unconscious bias training company-wide by 2023
Employee resource groups (ERGs) for women grew to 95% coverage in pharma multinationals in 2023
76% of pharma companies reported improved hiring rates for diverse candidates after DEI program implementation in 2023
Diverse candidate slates mandated in 82% of pharma job postings in 2022
Promotion rates for women in pharma rose 18% post-DEI interventions in 2023
Employee engagement scores for diverse groups rose 22% after DEI efforts in pharma 2023
Sense of belonging reported by 78% of women in pharma vs 85% men in 2023 surveys
Black employees' inclusion ratings improved to 65% in pharma 2022 from 52% in 2018
Women held 28% of executive positions in pharma companies in 2023, up from 22% in 2018
Black executives represented 4.2% of pharma C-suite roles in U.S. firms in 2023
Hispanic/Latino leaders made up 5.1% of senior pharma management in 2022
In 2023, women represented 52% of the total workforce in the U.S. pharmaceutical industry, up from 48% in 2018
Black or African American employees comprised 12.4% of the pharma workforce in 2022, compared to 13.6% of the U.S. population
Hispanic or Latino workers made up 14.2% of pharmaceutical company employees in 2023, showing a 2% increase over five years

Pharma is advancing DEI fast, with measurable gains in hiring, promotions, engagement, and retention.

01 · Category

Dei Programs And Investments20 stats

92% of large pharma companies invested over $10M in DEI initiatives in 2023

78% of pharma firms implemented unconscious bias training company-wide by 2023

Employee resource groups (ERGs) for women grew to 95% coverage in pharma multinationals in 2023

65% of pharma companies set DEI-specific KPIs tied to executive bonuses in 2022

Mentoring programs for underrepresented groups reached 82% of pharma firms in 2023

Supplier diversity spending by pharma increased 25% to $5B in 2023

70% of pharma cos conducted pay equity audits annually since 2021

DEI officer roles were created in 88% of Fortune 500 pharma firms by 2023

Inclusive leadership training covered 75% of managers in pharma in 2022

60% of pharma firms partnered with HBCUs for recruitment in 2023

Accessibility improvements in pharma workplaces reached 90% compliance in 2023

Pronoun policies were adopted by 55% of pharma companies in 2023

Cultural competency training was mandatory for 68% of sales teams in pharma 2022

45% of pharma budgets allocated to DEI rose from 1% to 2.5% avg in 2023

Affinity networks for Black employees existed in 92% of large pharma in 2023

Women's leadership forums sponsored 80% of pharma firms in 2022

Latino ERGs grew 40% in pharma companies from 2020-2023

Asian Pacific networks in pharma covered 85% of employees in 2023

Disability inclusion programs launched by 72% of pharma in 2023

Veteran ERGs present in 65% of pharma firms per 2023 survey

Interpretation

Dei Programs And Investments Interpretation

In the Dei Programs And Investments category, pharma made clear headway in 2023 with 92% of large companies investing over $10M in DEI initiatives and supplier diversity spending rising 25% to $5B.

02 · Category

Equity In Hiring And Promotion20 stats

76% of pharma companies reported improved hiring rates for diverse candidates after DEI program implementation in 2023

Diverse candidate slates mandated in 82% of pharma job postings in 2022

Promotion rates for women in pharma rose 18% post-DEI interventions in 2023

Black employee promotion to management increased to 8.5% in 2023 from 6% in 2019

Hispanic hires in entry-level pharma roles grew 22% year-over-year in 2023

Blind resume screening adopted by 67% of pharma recruiters in 2022

Internal promotion pipelines for minorities expanded in 75% of pharma in 2023

Women hired into senior roles increased 12% after targeted programs in 2023 pharma data

Pay gaps for Black employees narrowed to 11% in pharma after audits in 2022

Promotion disparities for Latinos reduced by 15% in pharma 2023 studies

Diverse interview panels standard in 80% of large pharma companies 2023

Retention bonuses for diverse hires offered by 55% of pharma in 2022

Succession planning included 40% diverse candidates in pharma 2023

Apprenticeships for underrepresented groups grew 30% in pharma hiring 2023

Gender pay equity achieved in 62% of pharma roles post-2023 adjustments

Asian American promotions to director level hit 9% in pharma 2023

Disability hiring quotas met by 48% of pharma firms in 2022

LGBTQ+ recruitment campaigns boosted hires by 20% in pharma 2023

Veteran hiring initiatives led to 12% increase in pharma employment 2023

Indigenous recruitment partnerships yielded 25% more hires in pharma 2023

Interpretation

Equity In Hiring And Promotion Interpretation

Equity in hiring and promotion is showing clear momentum, with 82% of pharma job postings requiring diverse candidate slates in 2022 and subsequent gains like women’s promotion rates rising 18% after DEI interventions in 2023.

03 · Category

Inclusion And Employee Experience20 stats

Employee engagement scores for diverse groups rose 22% after DEI efforts in pharma 2023

Sense of belonging reported by 78% of women in pharma vs 85% men in 2023 surveys

Black employees' inclusion ratings improved to 65% in pharma 2022 from 52% in 2018

Turnover rates for diverse employees dropped 15% post-inclusion programs in pharma 2023

85% of pharma workers felt psychologically safe in diverse teams per 2023 data

Hispanic employees reported 72% satisfaction with inclusion initiatives in 2023 pharma polls

Net promoter scores for DEI in pharma averaged 45 in 2023 employee surveys

Flexible work policies boosted inclusion for parents by 30% in pharma 2022

Mental health support utilization rose 28% among diverse pharma staff in 2023

Allyship training led to 20% higher inclusion scores in pharma teams 2023

Innovation idea submissions from underrepresented groups up 35% in pharma 2023

Feedback survey participation hit 92% in diverse pharma units 2022

Cross-cultural team effectiveness rated 82% positive in pharma 2023

ERG participation correlated with 18% higher retention in pharma 2023

Inclusion index for Asians in pharma reached 75% in 2023 benchmarks

Disability employee experience scores improved 25% after accommodations in 2023 pharma

LGBTQ+ inclusion ratings at 80% in leading pharma firms 2023

Veteran belonging scores averaged 78% in pharma workplaces 2023

Grievance resolution for discrimination down 40% in pharma with DEI 2023

Overall DEI maturity score for pharma industry was 6.8/10 in 2023 assessments

Interpretation

Inclusion And Employee Experience Interpretation

In the pharma industry, inclusion efforts appear to be translating into better employee experiences, with diverse-group engagement rising 22% in 2023 and psychological safety reaching 85% in diverse teams, alongside turnover for diverse employees dropping 15% after inclusion programs.

Diversity Equity And Inclusion In IndustryDiversity Equity And Inclusion In The Commercial Industry Statistics

04 · Category

Leadership And Executive Diversity23 stats

Women held 28% of executive positions in pharma companies in 2023, up from 22% in 2018

Black executives represented 4.2% of pharma C-suite roles in U.S. firms in 2023

Hispanic/Latino leaders made up 5.1% of senior pharma management in 2022

Asian executives comprised 11.8% of pharma board seats globally in 2023

Women CEOs in top 20 pharma companies increased to 15% in 2023 from 5% in 2015

Board chairs who are women rose to 12% in pharma industry in 2023

Black women in pharma VP roles were 2.1% in 2023 surveys

35% of pharma board members were women in S&P 500 pharma firms in 2023

Ethnic minority executives reached 18% in European pharma leadership in 2022

Pharma CFO positions held by women were 24% in 2023 global data

R&D heads who are women increased to 22% in top pharma in 2023

Board diversity index for pharma averaged 0.45 (women+minorities) in 2023

Latino men in C-suite pharma roles were 2.9% in 2023

Women in pharma CMO roles reached 30% in 2022

Asian women executives were 4.5% of pharma leadership in 2023

Disability representation in pharma boards was 3.2% self-identified in 2023

LGBTQ+ executives in pharma were 3.8% in 2023 voluntary disclosures

Veteran leaders in pharma C-suite hit 4.1% in 2023

Indigenous representation in pharma leadership was 0.8% in North America 2023

Multiracial executives in pharma were 1.5% of senior roles in 2022

White men held 52% of pharma executive positions in 2023, down from 65% in 2015

Pharma companies with 30%+ women in leadership saw 15% higher innovation rates in 2023 studies

85% of top pharma firms launched DEI training programs for executives in 2022

Interpretation

Leadership And Executive Diversity Interpretation

Leadership and executive diversity in pharma is improving, with women reaching 28% of executive roles in 2023 up from 22% in 2018 and women CEOs rising to 15% in 2023 from 5% in 2015, though representation for other groups such as Black executives at 4.2% and Hispanic or Latino leaders at 5.1% remains relatively low.

05 · Category

Representation In Workforce29 stats

In 2023, women represented 52% of the total workforce in the U.S. pharmaceutical industry, up from 48% in 2018

Black or African American employees comprised 12.4% of the pharma workforce in 2022, compared to 13.6% of the U.S. population

Hispanic or Latino workers made up 14.2% of pharmaceutical company employees in 2023, showing a 2% increase over five years

Asian employees accounted for 18.7% of the pharma sector workforce in North America as of 2023

Employees with disabilities represented 4.8% of the total pharma workforce in 2022 surveys

LGBTQ+ identification among pharma workers stood at 7.2% in 2023 internal audits

Veterans comprised 6.5% of the pharmaceutical industry workforce in 2023

Entry-level positions in pharma had 55% female representation in 2023

Mid-level pharma roles showed 48% women in 2022 data

Non-binary gender identification was reported at 1.2% in pharma workforce surveys of 2023

Indigenous employees made up 1.1% of the pharma workforce in Canada and U.S. combined in 2023

Multiracial employees represented 3.4% in U.S. pharma firms in 2022 EEOC filings

White employees decreased to 61.2% of pharma workforce from 65% in 2018, per 2023 data

Pharma R&D roles had 42% women in 2023 global survey

Manufacturing roles in pharma showed 38% female workers in 2022

Sales and marketing teams in pharma had 47% women representation in 2023

IT and digital roles in pharma reached 35% women in 2023

Regulatory affairs positions had 60% women in 2022 surveys

Clinical operations roles showed 51% female staffing in 2023

Supply chain pharma roles had 45% women in 2023 data

Finance and accounting in pharma had 55% women representation in 2022

HR departments in pharma were 68% women in 2023 audits

Legal teams in pharmaceutical companies showed 52% women in 2023

Women in pharma workforce aged 25-34 were 28% of total women employees in 2022

Black women represented 5.8% of pharma workforce in 2023 U.S. data

Hispanic men in pharma workforce were 8.1% in 2022

Asian women in pharma reached 10.2% of workforce in 2023

Employees over 55 years old were 22% of pharma workforce, with diversity gaps

Part-time workers in pharma showed 62% women in 2023 surveys

Interpretation

Representation In Workforce Interpretation

Within the Representation In Workforce category, women have grown to 52% of the U.S. pharmaceutical workforce in 2023 from 48% in 2018, while other underrepresented groups show more uneven progress such as Hispanic or Latino employees rising to 14.2% in 2023.

Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA

Kevin O'Brien. (2026, February 13). Diversity Equity And Inclusion In The Pharma Industry Statistics. Gitnux. https://gitnux.org/diversity-equity-and-inclusion-in-the-pharma-industry-statistics

MLA

Kevin O'Brien. "Diversity Equity And Inclusion In The Pharma Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/diversity-equity-and-inclusion-in-the-pharma-industry-statistics.

Chicago

Kevin O'Brien. 2026. "Diversity Equity And Inclusion In The Pharma Industry Statistics." Gitnux. https://gitnux.org/diversity-equity-and-inclusion-in-the-pharma-industry-statistics.